# FDA recall D-0944-2020

> **Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical** · Class II · drug recall initiated 2020-01-15.

## Product

BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [5ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well. 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0621-5

## Reason for recall

Lack of Assurance of Sterility

## Distribution

U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

## Key facts

- **Recall number:** D-0944-2020
- **Recalling firm:** Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-01-15
- **Report date:** 2020-03-11
- **Termination date:** 2023-12-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Los Angeles, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0944-2020

## Citation

> AI Analytics. FDA recall D-0944-2020. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0944-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*